Optimizing Antiemetic Strategies Across Phases of Chemotherapy-Induced Nausea and Vomiting: Real-World Evidence in Breast Cancer

Background: Chemotherapy-induced nausea and vomiting (CINV) remains one of the significant challenges in oncology despite guideline-based prophylaxis, particularly in patients receiving highly emetogenic chemotherapy (HEC). While neurokinin-1 (NK-1) receptor antagonists are established as a key comp...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Akif Doğan, Hande Nur Erölmez, Goncagül Akdağ, Sedat Yıldırım, Özlem Nuray Sever
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2026-01-01
Ráidu:	Current Oncology
Fáttát:	chemotherapy-induced nausea and vomiting highly emetogenic chemotherapy neurokinin-1 receptor antagonists aprepitant fosaprepitant breast cancer
Liŋkkat:	https://www.mdpi.com/1718-7729/33/2/78
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!